Identification of an anaplastic subtype of prostate cancer amenable to therapies targeting SP1 or translation elongation
Favorite
Share
More Options
19

Open in WPS to view all 19 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
